STERIS plc STE

Full chart Compare
Set alert

Price alert · STE

All alert types
251.89 USD +3.98 (+1.61%)

Nov 5, 2026, 12:54 PM EST

247.68 Day range 259.25
199.40 52-week range 268.65
YTD
-0.64%
1 year
+3.58%
Market cap
24.53B
Revenue (ttm)
6.04B
Profit margin
13.33%
EPS (ttm)
8.18
Shares out
97.50M
P/E ratio
30.76
Forward P/E
20.13
Dividend
2.76 (1.18%)
Ex-dividend date
Nov 16, 2026
YTD return
-0.64%
1-year return
+3.58%
Volume
743.82K
Avg volume
686.36K
Open
252.35
Previous close
247.91
Day's range
247.68 – 259.25
52-week range
199.40 – 268.65
Beta
0.86
Analysts
Buy
Price target
260.71 (+3.5%)
Earnings date
Feb 3, 2027

5D +18.39 (+7.89%)

230240250260FriMonTueWedThu251.59

Key statistics

Enterprise value
24.13B
PEG ratio
1.79
Price / sales
4.01
Price / book
3.36
Dividend yield
1.19%
Payout ratio
30.81%
Revenue growth
7.30%
Free cash flow
798.86M
Total cash
482.30M
Total debt
2.04B
Return on equity
11.39%
Short % of float
2.47%
50-day average
219.61
200-day average
224.36

Financials — quick view

All financials
STE Revenue — quarterly 1.49B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
STE Net income — quarterly 200.10M
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
STE EPS — quarterly 2.05
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

STE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 3, 2027Dec 30, 20262.81———
Nov 4, 2026Sep 30, 20262.682.94+0.26+9.70%
Aug 5, 2026Jun 30, 20262.492.59+0.10+4.02%
May 11, 2026Mar 31, 20262.852.83-0.02-0.70%
Feb 4, 2026Dec 31, 20252.532.530.000.00%
Nov 5, 2025Sep 30, 20252.352.47+0.12+5.11%

Upgrades / downgrades

STE analyst upgrades and downgrades
DateFirmActionFromTo
Aug 7, 2026UBSmainBuyBuy
Aug 7, 2026Piper SandlerreitOverweightOverweight
Jul 28, 2026UBSinit—Buy
May 13, 2026KeybancmainOverweightOverweight
Aug 8, 2025Morgan StanleymainOverweightOverweight
Jul 22, 2025KeybancmainOverweightOverweight

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
steris.com

News

Your note

Sign in to keep a note on STE — it syncs with the Stock Master app.

Institution ownership

STE institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.05%8,820,8892.19BJun 29, 2026
Vanguard Capital Management LLC6.57%6,406,9061.59BJun 29, 2026
State Street Corporation5.20%5,072,8181.26BJun 29, 2026
Vanguard Portfolio Management LLC5.13%5,001,9501.24BJun 29, 2026
Morgan Stanley4.05%3,950,067980.53MJun 29, 2026
Massachusetts Financial Services Co.3.90%3,801,077943.54MJun 29, 2026

Fund ownership

STE fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%3,114,554773.13MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.61%2,542,447631.11MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.18%2,124,977527.48MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%1,299,580322.59MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%1,267,104314.53MSep 29, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.25%1,216,185301.89MSep 29, 2026